HUP0004936A3 - Use of bendazac for producing pharmaceutical composition for reducing production of mcp-1 proten - Google Patents
Use of bendazac for producing pharmaceutical composition for reducing production of mcp-1 protenInfo
- Publication number
- HUP0004936A3 HUP0004936A3 HU0004936A HUP0004936A HUP0004936A3 HU P0004936 A3 HUP0004936 A3 HU P0004936A3 HU 0004936 A HU0004936 A HU 0004936A HU P0004936 A HUP0004936 A HU P0004936A HU P0004936 A3 HUP0004936 A3 HU P0004936A3
- Authority
- HU
- Hungary
- Prior art keywords
- proten
- bendazac
- mcp
- pharmaceutical composition
- reducing production
- Prior art date
Links
- 101100504320 Caenorhabditis elegans mcp-1 gene Proteins 0.000 title 1
- BYFMCKSPFYVMOU-UHFFFAOYSA-N bendazac Chemical compound C12=CC=CC=C2C(OCC(=O)O)=NN1CC1=CC=CC=C1 BYFMCKSPFYVMOU-UHFFFAOYSA-N 0.000 title 1
- 229960005149 bendazac Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT97MI001788A IT1293794B1 (it) | 1997-07-28 | 1997-07-28 | Farmaco attivo nel ridurre la produzione di proteina mcp-1 |
| PCT/EP1998/004925 WO1999004791A1 (en) | 1997-07-28 | 1998-07-22 | A pharmaceutical composition active in reducing production of mcp-1 protein |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0004936A2 HUP0004936A2 (hu) | 2001-11-28 |
| HUP0004936A3 true HUP0004936A3 (en) | 2002-01-28 |
Family
ID=11377641
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0004936A HUP0004936A3 (en) | 1997-07-28 | 1998-07-22 | Use of bendazac for producing pharmaceutical composition for reducing production of mcp-1 proten |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6191158B1 (hu) |
| EP (1) | EP0999836A1 (hu) |
| JP (1) | JP2001510802A (hu) |
| KR (1) | KR20010022333A (hu) |
| CN (1) | CN1265592A (hu) |
| AU (1) | AU9160298A (hu) |
| BG (1) | BG104162A (hu) |
| CA (1) | CA2298507A1 (hu) |
| EA (1) | EA200000168A1 (hu) |
| HU (1) | HUP0004936A3 (hu) |
| IL (1) | IL134050A0 (hu) |
| IT (1) | IT1293794B1 (hu) |
| SK (1) | SK1332000A3 (hu) |
| TR (1) | TR200000244T2 (hu) |
| WO (1) | WO1999004791A1 (hu) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20062254A1 (it) | 2006-11-24 | 2008-05-25 | Acraf | Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3970194A (en) * | 1975-01-08 | 1976-07-20 | Philip Morris Incorporated | Razor blade cartridge and display article |
| IT1147079B (it) * | 1980-05-30 | 1986-11-19 | Sigma Tau Ind Farmacuetiche Ri | Esteri di alcossi-acil derivati della carnitina procedimento per la loro preparatione e composizioni farmaceutiche che li contengono |
| IT1131779B (it) * | 1980-07-29 | 1986-06-25 | Acraf | Sale dell'acido (1-benzil-1h-indazol-3-il)-ossiacetico con la lisina e procedimento per la sua preparazione |
| IT1189052B (it) * | 1981-11-27 | 1988-01-28 | Acraf | Trattamento della cataratta |
| IT1197805B (it) * | 1986-08-01 | 1988-12-06 | Acraf | Metodo per il tratamento di lenti a contatto |
-
1997
- 1997-07-28 IT IT97MI001788A patent/IT1293794B1/it active IP Right Grant
-
1998
- 1998-07-22 CA CA002298507A patent/CA2298507A1/en not_active Abandoned
- 1998-07-22 IL IL13405098A patent/IL134050A0/xx unknown
- 1998-07-22 EP EP98943863A patent/EP0999836A1/en not_active Withdrawn
- 1998-07-22 HU HU0004936A patent/HUP0004936A3/hu unknown
- 1998-07-22 KR KR1020007000912A patent/KR20010022333A/ko not_active Application Discontinuation
- 1998-07-22 CN CN98807694A patent/CN1265592A/zh active Pending
- 1998-07-22 SK SK133-2000A patent/SK1332000A3/sk unknown
- 1998-07-22 AU AU91602/98A patent/AU9160298A/en not_active Abandoned
- 1998-07-22 JP JP2000503846A patent/JP2001510802A/ja active Pending
- 1998-07-22 US US09/463,665 patent/US6191158B1/en not_active Expired - Fee Related
- 1998-07-22 EA EA200000168A patent/EA200000168A1/ru unknown
- 1998-07-22 WO PCT/EP1998/004925 patent/WO1999004791A1/en not_active Application Discontinuation
- 1998-07-22 TR TR2000/00244T patent/TR200000244T2/xx unknown
-
2000
- 2000-02-17 BG BG104162A patent/BG104162A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TR200000244T2 (tr) | 2000-09-21 |
| KR20010022333A (ko) | 2001-03-15 |
| EP0999836A1 (en) | 2000-05-17 |
| IL134050A0 (en) | 2001-04-30 |
| ITMI971788A1 (it) | 1999-01-28 |
| BG104162A (en) | 2000-12-29 |
| IT1293794B1 (it) | 1999-03-10 |
| HUP0004936A2 (hu) | 2001-11-28 |
| SK1332000A3 (en) | 2000-12-11 |
| AU9160298A (en) | 1999-02-16 |
| EA200000168A1 (ru) | 2000-08-28 |
| CN1265592A (zh) | 2000-09-06 |
| WO1999004791A1 (en) | 1999-02-04 |
| JP2001510802A (ja) | 2001-08-07 |
| US6191158B1 (en) | 2001-02-20 |
| CA2298507A1 (en) | 1999-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0749751A3 (en) | Pharmaceutical composition for use in the treatment of diabetes | |
| HUT71633A (en) | Production of polyisobutenes | |
| HK1025904A1 (en) | Pharmaceutical composition for combination of piperidinoalkanol-decongestant | |
| IL125809A (en) | Process and intermediates for production of donepezil and related compounds | |
| IL187181A (en) | Polymorph of a pharmaceutical | |
| HU9800291D0 (en) | Use of amido-pirimidine derivatives for producing pharmaceutical compositions for inhibiting decrease of glucose-metabolismus | |
| CZ20011657A3 (cs) | Nové piperazinové a piperidinové sloučeniny, způsob jejich přípravy a jejich pouľití | |
| EG22344A (en) | Process for preparing of novel pharmaceutical composition | |
| HK1028561A1 (en) | Pharmaceutical composition for reducing production of mcp-1 protein | |
| GB9800855D0 (en) | Production of alumina | |
| HUP0004936A3 (en) | Use of bendazac for producing pharmaceutical composition for reducing production of mcp-1 proten | |
| PL335347A1 (en) | Selective epoxidising process for use in production of pharmaceutic compounds | |
| ZA98898B (en) | Process for the production of halogeno-o-hydroxydiphenyl compounds | |
| IL133558A0 (en) | Production of avermectin compounds | |
| HUP9802495A3 (en) | Process for producing of formyl-imidazole-derivatives | |
| HUP0002715A3 (en) | Use of benzotiophen derivatives for production of pharmaceutical compositions for lowering platelet counts | |
| HU9800009D0 (en) | Process for production of mould | |
| SG77121A1 (en) | Production of methylamines | |
| GB2288807B (en) | Production of delta-latroinsectotoxin | |
| HUP0103105A3 (en) | Process for the synthesis of exochelins | |
| TW350593U (en) | Improvement of forming mold for semicondutor | |
| GB2287880A8 (en) | Production of sustained release compositions | |
| PL303086A1 (en) | Ceramic body for production of not-fired ceramic building materials | |
| TW398403U (en) | Improved structure of mold for making wave-breaking block | |
| TW407579U (en) | Structure of mold for hollow forming |